| Market Cap | 361M 318M 293M 274M 514M 34.05B 524M 3.53B 1.37B 16.8B 1.36B 1.33B 58.44B | P/E 2026 * |
39.7x | P/E 2027 * | 11x |
|---|---|---|---|---|---|
| Enterprise Value | 361M 318M 293M 274M 514M 34.05B 524M 3.53B 1.37B 16.8B 1.36B 1.33B 58.44B | EV / Sales 2026 * |
5.17x | EV / Sales 2027 * | 3.6x |
| Free-Float |
81.4% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Fennec Pharmaceuticals Inc
| 1 day | +1.29% |
| Manager | Title | Age | Since |
|---|---|---|---|
Jeffrey Hackman
CEO | Chief Executive Officer | 64 | 2024-08-15 |
Robert Andrade
DFI | Director of Finance/CFO | 51 | 2010-01-05 |
Pierre Sayad
CTO | Chief Tech/Sci/R&D Officer | 51 | 2024-10-27 |
| Director | Title | Age | Since |
|---|---|---|---|
Chris Rallis
BRD | Director/Board Member | 72 | 2011-08-24 |
Khalid Islam
CHM | Chairman | 69 | 2015-12-08 |
Marco Brughera
BRD | Director/Board Member | 70 | 2016-08-09 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.29% | +3.66% | - | - | 361M | |
| +0.92% | +0.47% | +43.59% | +143.50% | 996B | |
| +0.80% | +2.90% | +58.35% | +45.64% | 580B | |
| +0.06% | +6.17% | +26.59% | +72.81% | 415B | |
| +3.67% | -2.44% | +22.01% | +15.66% | 326B | |
| -0.27% | +5.05% | +30.53% | +39.45% | 280B | |
| +0.38% | +6.02% | +36.08% | +23.50% | 284B | |
| +1.47% | +12.71% | -27.47% | -41.27% | 210B | |
| +1.27% | +2.86% | +26.65% | +54.74% | 190B | |
| +0.09% | -0.23% | +16.75% | +61.56% | 155B | |
| Average | +0.96% | +2.68% | +25.90% | +46.18% | 381.86B | |
| Weighted average by Cap. | +0.92% | +2.18% | +33.81% | +68.03% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 69.83M 61.47M 56.7M 53.03M 99.36M 6.58B 101M 681M 264M 3.25B 262M 256M 11.3B | 100M 88.43M 81.57M 76.29M 143M 9.47B 146M 980M 380M 4.67B 377M 369M 16.25B |
| Net income | 8.99M 7.91M 7.3M 6.83M 12.79M 847M 13.03M 87.73M 33.98M 418M 33.75M 33.02M 1.45B | 33.1M 29.14M 26.88M 25.14M 47.1M 3.12B 47.98M 323M 125M 1.54B 124M 122M 5.35B |
| Net Debt | - | - |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
